Feedback PLC Notice of Results (0123A)
January 31 2022 - 1:59AM
UK Regulatory
TIDMFDBK
RNS Number : 0123A
Feedback PLC
31 January 2022
Feedback plc
Notice of Results
London, 31 January 2022 : Feedback plc (AIM: FDBK, "Feedback" or
the "Company"), the specialist clinical communication company, will
announce results for the half year ended 30 November 2021 on
Thursday 10 February 2022.
Analyst Briefing, 9:30am, Thursday 10 February 2022
A briefing for Analysts will be held at 9:30am GMT on the day of
the results.
Analysts interested in attending should contact Walbrook PR by
emailing feedbackplc@walbrookpr.com or by calling 020 7933
8780.
Further information on Feedback and its products can be found on
the Company's website:
https://fbkmed.com/feedback-plc/reports-and-presentations/
-Ends-
Enquiries:
Feedback plc +44 (0) 20 3997 7634
Tom Oakley, CEO IR@fbk.com
Anesh Patel, CFO
Panmure Gordon (UK) Limited (NOMAD
and Broker)
Emma Earl/Freddy Crossley (Corporate
Finance)
Rupert Dearden (Corporate Broking) +44 (0)20 7886 2500
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236
Johnson or 07884 664 686
About Feedback
Feedback plc is a specialist clinical communications business,
with a mission to improve the efficiency and quality of
communications for frontline clinicians and hospitals with a key
focus on building solutions that enhance access to high quality
patient data.
Feedback has developed a toolkit of clinical communications
apps. Its core, regulatory approved product is Bleepa, a
revolutionary medical imaging app enabling remote and secure
communications between frontline clinicians and teams. CareLocker
is an evolutionary GDPR compliant patient-centric cloud
architecture - its proprietary technology enables an easy route to
creation and mobilisation of individual healthcare records. Bleepa
Box is a specialist tool to enable image transfer from remote
settings to the Bleepa platform over mobile networks.
The Company has a number of growth opportunities domestically
and internationally across a range of markets including the NHS,
the veterinary market and private healthcare providers and its
highly scalable Software as a Service ("SaaS")-based revenue model
is expected to provide increasing levels of visibility as the
Company grows its customer base.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOREAFFPALFAEFA
(END) Dow Jones Newswires
January 31, 2022 01:59 ET (06:59 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Jul 2024 to Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From Jul 2023 to Jul 2024